Aquarius Surgical Technologies Inc.
AQQRF
$0.00
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 42.94% | 19.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 42.94% | 19.85% | |||
| Cost of Revenue | 15.48% | 27.27% | |||
| Gross Profit | 72.15% | 12.86% | |||
| SG&A Expenses | 13.08% | -52.68% | |||
| Depreciation & Amortization | -100.00% | -67.35% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.71% | -47.39% | |||
| Operating Income | 9.61% | 60.20% | |||
| Income Before Tax | 105.05% | 28.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 105.05% | 28.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 105.05% | 28.55% | |||
| EBIT | 9.61% | 60.20% | |||
| EBITDA | 10.19% | 59.67% | |||
| EPS Basic | 105.26% | 28.64% | |||
| Normalized Basic EPS | 4.35% | 30.30% | |||
| EPS Diluted | 105.26% | 28.64% | |||
| Normalized Diluted EPS | 4.35% | 30.30% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||